# Atea Pharmaceuticals, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:b7501c6c-b71e-410c-9417-edc16acc3e24 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/atea-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 33 | | Claims under review | 1 | | Evidence records | 9 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-22T04:46:27.103907+00:00 | | Last reviewed | 2026-10-22T04:46:27.103907+00:00 | ## Identity - Legal name: Atea Pharmaceuticals, Inc. - Display name: Atea Pharmaceuticals, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-22T06:32:45.319904+00:00 | | Completeness | 0.409 | | Record Quality | 0.842 | | Directors | 9 | | Committees | 8 | | Governance events | 26 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Arthur Kirsch: Director. Status: current. Independent: true. Since: 2025-01-01. Committees: Audit (member); Audit; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:5 - Barbara Duncan: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (chair); Audit · Chair; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:6 - Bruce W. Polsky, MD, MACP, FIDSA: Director. Status: current. Independent: true. Since: 2014-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:7 - Bruno Lucidi: Director. Status: current. Independent: true. Since: 2014-01-01. Committees: Audit (member); Audit; Compensation (member); Compensation (member). claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:8 - Franklin Berger: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Audit (member); Audit; Compensation · Chair (member); Compensation (chair). claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:9 - Howard H. Berman, PhD: Director. Status: current. Independent: true. Since: 2025-01-01. claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:10 - Jean-Pierre Sommadossi, PhD: Director. Status: current. Independent: false. Since: 2014-01-01. claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:11 - Jerome Adams, MD, MPH: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Nominating and Governance (member). claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:12 - Polly A. Murphy, DVM, PhD: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Nominating and Governance (chair); Nominating and Governance · Chair (member). claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:13 ## Committees - Audit (audit). Chair: Barbara Duncan. Members: Barbara Duncan (chair, current); Arthur Kirsch (member, current); Bruno Lucidi (member, current); Franklin Berger (member, current). committee_id=alpha:committee:atea-pharmaceuticals-inc:audit - Audit · Chair; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Barbara Duncan (member, current). committee_id=alpha:committee:atea-pharmaceuticals-inc:audit-chair-nominating-and-governance - Audit; Compensation (audit). Chair: NOT_PUBLISHED. Members: Bruno Lucidi (member, current). committee_id=alpha:committee:atea-pharmaceuticals-inc:audit-compensation - Audit; Compensation · Chair (audit). Chair: NOT_PUBLISHED. Members: Franklin Berger (member, current). committee_id=alpha:committee:atea-pharmaceuticals-inc:audit-compensation-chair - Audit; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Arthur Kirsch (member, current). committee_id=alpha:committee:atea-pharmaceuticals-inc:audit-nominating-and-governance - Compensation (compensation). Chair: Franklin Berger. Members: Franklin Berger (chair, current); Bruce W. Polsky, MD, MACP, FIDSA (member, current); Bruno Lucidi (member, current). committee_id=alpha:committee:atea-pharmaceuticals-inc:compensation - Nominating and Governance (nominating_governance). Chair: Polly A. Murphy, DVM, PhD. Members: Polly A. Murphy, DVM, PhD (chair, current); Arthur Kirsch (member, current); Barbara Duncan (member, current); Jerome Adams, MD, MPH (member, current). committee_id=alpha:committee:atea-pharmaceuticals-inc:nominating-and-governance - Nominating and Governance · Chair (nominating_governance). Chair: NOT_PUBLISHED. Members: Polly A. Murphy, DVM, PhD (member, current). committee_id=alpha:committee:atea-pharmaceuticals-inc:nominating-and-governance-chair ## Executive leadership - Andrea Corcoran: Chief Financial Officer, Executive Vice President, Legal and Secretary [CFO]. Status: current. claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:14 - Janet Hammond, M.D., Ph.D.: Chief Development Officer. Status: current. claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:15 - Jean-Pierre Sommadossi, Ph.D.: President and Chief Executive Officer and Chairman of the Board of Directors [CEO]. Status: current. claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:16 - John Vavricka: Chief Commercial Officer. Status: current. claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:17 - Maria Arantxa Horga, M.D.: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:18 - Wayne Foster: Executive Vice President and Chief Accounting Officer [CAO]. Status: current. claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:19 ## Governance events - CFO_CHANGED: Andrea Corcoran executive of Atea Pharmaceuticals, Inc., effective 2026-03-05. Effective: 2026-03-05. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:26bdma1auw4zg - EXECUTIVE_APPOINTED: Janet Hammond, M.D., Ph.D. executive of Atea Pharmaceuticals, Inc., effective 2026-03-05. Effective: 2026-03-05. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:199g6dymly5ak - CEO_CHANGED: Jean-Pierre Sommadossi, Ph.D. executive of Atea Pharmaceuticals, Inc., effective 2026-03-05. Effective: 2026-03-05. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1pduv5igp5p7g - EXECUTIVE_APPOINTED: John Vavricka executive of Atea Pharmaceuticals, Inc., effective 2026-03-05. Effective: 2026-03-05. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1qp7z7lg9fgzv - EXECUTIVE_APPOINTED: Maria Arantxa Horga, M.D. executive of Atea Pharmaceuticals, Inc., effective 2026-03-05. Effective: 2026-03-05. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1ozkzxx33w54r - EXECUTIVE_APPOINTED: Wayne Foster executive of Atea Pharmaceuticals, Inc., effective 2026-03-05. Effective: 2026-03-05. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1kwdfrtpgig2r - DIRECTOR_APPOINTED: Arthur Kirsch seat on Atea Pharmaceuticals, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1cjm4w218agkhs - DIRECTOR_APPOINTED: Howard H. Berman, PhD seat on Atea Pharmaceuticals, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1sk9kdigjyrto - COMMITTEE_CREATED: Audit; Nominating and Governance committee of Atea Pharmaceuticals, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1x41vear6tgxk - COMMITTEE_MEMBER_ADDED: Arthur Kirsch member of Audit; Nominating and Governance, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:opswodjls8dd - DIRECTOR_APPOINTED: Jerome Adams, MD, MPH seat on Atea Pharmaceuticals, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:ljgrzwksidqq - DIRECTOR_APPOINTED: Barbara Duncan seat on Atea Pharmaceuticals, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:2z05pm1lyolnm - DIRECTOR_APPOINTED: Polly A. Murphy, DVM, PhD seat on Atea Pharmaceuticals, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:5mxee28wdxce - COMMITTEE_CREATED: Audit · Chair; Nominating and Governance committee of Atea Pharmaceuticals, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1w8228ifyog8i - COMMITTEE_MEMBER_ADDED: Barbara Duncan member of Audit · Chair; Nominating and Governance, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:b2pp6v1fjjpaz - COMMITTEE_CREATED: Nominating and Governance · Chair committee of Atea Pharmaceuticals, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:9f43pe1r3wqqu - COMMITTEE_MEMBER_ADDED: Polly A. Murphy, DVM, PhD member of Nominating and Governance · Chair, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1ugesp71qdgeu7 - DIRECTOR_APPOINTED: Franklin Berger seat on Atea Pharmaceuticals, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:102j22x68atgz - COMMITTEE_CREATED: Audit; Compensation · Chair committee of Atea Pharmaceuticals, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:bcpem11i6maz - COMMITTEE_MEMBER_ADDED: Franklin Berger member of Audit; Compensation · Chair, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1jeklhhrbj2q1 - DIRECTOR_APPOINTED: Bruce W. Polsky, MD, MACP, FIDSA seat on Atea Pharmaceuticals, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1mb4f3419b7aa4 - DIRECTOR_APPOINTED: Bruno Lucidi seat on Atea Pharmaceuticals, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1bi6oc1jgg3hr - DIRECTOR_APPOINTED: Jean-Pierre Sommadossi, PhD seat on Atea Pharmaceuticals, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:b1l0251grv7an - COMMITTEE_CREATED: Audit; Compensation committee of Atea Pharmaceuticals, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1nu6twx1efbssf - COMMITTEE_MEMBER_ADDED: Bruno Lucidi member of Audit; Compensation, effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:2ohtg71awoblp - COMMITTEE_MEMBER_ADDED: Bruce W. Polsky, MD, MACP, FIDSA member of Compensation, effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:rjeq2uh06ye ## Scoped resources - `alpha://company/atea-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record - `alpha://company/atea-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/atea-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/atea-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=board - `alpha://company/atea-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/atea-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/atea-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/atea-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/atea-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/atea-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/atea-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/atea-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/atea-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/atea-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/atea-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/atea-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/atea-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/atea-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/atea-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/atea-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=events - `alpha://company/atea-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/atea-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/atea-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:barbara-duncan","name":"Barbara Duncan"},"source_id":"board_seats"}` - Claim alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:arthur-kirsch","name":"Arthur Kirsch"},"source_id":"board_seats"}` - Claim alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:bruno-lucidi","name":"Bruno Lucidi"},"source_id":"board_seats"}` - Claim alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:franklin-berger","name":"Franklin Berger"},"source_id":"board_seats"}` - Claim alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:franklin-berger","name":"Franklin Berger"},"source_id":"board_seats"}` - Claim alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:bruce-w-polsky-md-macp-fidsa","name":"Bruce W. Polsky, MD, MACP, FIDSA"},"source_id":"board_seats"}` - Claim alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:28: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:bruno-lucidi","name":"Bruno Lucidi"},"source_id":"board_seats"}` - Claim alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:30: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:polly-a-murphy-dvm-phd","name":"Polly A. Murphy, DVM, PhD"},"source_id":"board_seats"}` - Claim alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:31: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:arthur-kirsch","name":"Arthur Kirsch"},"source_id":"board_seats"}` - Claim alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:32: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:barbara-duncan","name":"Barbara Duncan"},"source_id":"board_seats"}` - Claim alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:33: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:jerome-adams-md-mph","name":"Jerome Adams, MD, MPH"},"source_id":"board_seats"}` ## Leadership - Arthur Kirsch: Director, Audit; Nominating and Governance. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:5. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a4700459dfc77ee8a7c9a0cb0af22f79475f321f8ed32f9ddacb4c85a1b02168. - Barbara Duncan: Director, Audit · Chair; Nominating and Governance. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:6. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a4700459dfc77ee8a7c9a0cb0af22f79475f321f8ed32f9ddacb4c85a1b02168. - Bruce W. Polsky, MD, MACP, FIDSA: Director, Compensation. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:7. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a4700459dfc77ee8a7c9a0cb0af22f79475f321f8ed32f9ddacb4c85a1b02168. - Bruno Lucidi: Director, Audit; Compensation. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:8. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a4700459dfc77ee8a7c9a0cb0af22f79475f321f8ed32f9ddacb4c85a1b02168. - Franklin Berger: Director, Audit; Compensation · Chair. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:9. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a4700459dfc77ee8a7c9a0cb0af22f79475f321f8ed32f9ddacb4c85a1b02168. - Howard H. Berman, PhD: Director. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:10. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a4700459dfc77ee8a7c9a0cb0af22f79475f321f8ed32f9ddacb4c85a1b02168. - Jean-Pierre Sommadossi, PhD: Director. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:11. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a4700459dfc77ee8a7c9a0cb0af22f79475f321f8ed32f9ddacb4c85a1b02168. - Jerome Adams, MD, MPH: Director, Nominating and Governance. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:12. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a4700459dfc77ee8a7c9a0cb0af22f79475f321f8ed32f9ddacb4c85a1b02168. - Polly A. Murphy, DVM, PhD: Director, Nominating and Governance · Chair. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:13. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a4700459dfc77ee8a7c9a0cb0af22f79475f321f8ed32f9ddacb4c85a1b02168. - Andrea Corcoran: Chief Financial Officer, Executive Vice President, Legal and Secretary. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:14. Valid from: 2026-03-05. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9953e8211c98d4f1db61fe1f2c32217765f41f532ecf501efc46ef5032f59c9d. - Janet Hammond, M.D., Ph.D.: Chief Development Officer. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:15. Valid from: 2026-03-05. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:40cc738b5fbd3fa003b7c1829117fe79cd6a470b7c94e2517c01938d7c88459f. - Jean-Pierre Sommadossi, Ph.D.: President and Chief Executive Officer and Chairman of the Board of Directors. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:16. Valid from: 2026-03-05. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c16946c22a0f7642cf389ef5571c6bde253d8c4508114ec8ab1999b8c832ccd0. - John Vavricka: Chief Commercial Officer. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:17. Valid from: 2026-03-05. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9ff6707f20fd707526e2ce84ab2a965565c356ba38434025f7493e71883eb924. - Maria Arantxa Horga, M.D.: Chief Medical Officer. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:18. Valid from: 2026-03-05. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b2f3451aaeeb0f8396e6762730cb2743b7b44148603ba57c10f06133a7bfd2c6. - Wayne Foster: Executive Vice President and Chief Accounting Officer. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:19. Valid from: 2026-03-05. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:384f36b2791a1c51feaabbd002b0117f0ae301c9489f9a564efeff6ea674a775. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Barbara Duncan; Members Barbara Duncan (Chair); Arthur Kirsch; Bruno Lucidi; Franklin Berger. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab. - Compensation: Chair Franklin Berger; Members Franklin Berger (Chair); Bruce W. Polsky, MD, MACP, FIDSA; Bruno Lucidi. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_record:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab. - Nominating and Governance: Chair Polly A. Murphy, DVM, PhD; Members Polly A. Murphy, DVM, PhD (Chair); Arthur Kirsch; Barbara Duncan; Jerome Adams, MD, MPH. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_record:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Atea Pharmaceuticals, Inc.. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3c1e89afa4e1533f447d3f2ca5262abc82d5d72c421b456760bf7afce730f1c5. ## Entity Status - Public listing published. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3c1e89afa4e1533f447d3f2ca5262abc82d5d72c421b456760bf7afce730f1c5. ## Published Fact - US. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3c1e89afa4e1533f447d3f2ca5262abc82d5d72c421b456760bf7afce730f1c5. ## Committee Appointment - Barbara Duncan: chair, Audit. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab. - Arthur Kirsch: member, Audit. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab. - Bruno Lucidi: member, Audit. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab. - Franklin Berger: member, Audit. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab. - Franklin Berger: chair, Compensation. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab. - Bruce W. Polsky, MD, MACP, FIDSA: member, Compensation. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab. - Bruno Lucidi: member, Compensation. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab. - Polly A. Murphy, DVM, PhD: chair, Nominating and Governance. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab. - Arthur Kirsch: member, Nominating and Governance. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab. - Barbara Duncan: member, Nominating and Governance. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab. - Jerome Adams, MD, MPH: member, Nominating and Governance. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:33. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab. ## Security Listing - AVIR (NASDAQ). Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:security_listing:34. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3c1e89afa4e1533f447d3f2ca5262abc82d5d72c421b456760bf7afce730f1c5. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:3c1e89afa4e1533f447d3f2ca5262abc82d5d72c421b456760bf7afce730f1c5: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/atea-pharmaceuticals-inc). - alpha:projection-evidence:document:a4700459dfc77ee8a7c9a0cb0af22f79475f321f8ed32f9ddacb4c85a1b02168: [Atea Pharmaceuticals, Inc. DEF 14A 2025-04-29](https://www.sec.gov/Archives/edgar/data/1593899/000119312525104019/d931077ddef14a.htm). - alpha:projection-evidence:document:9953e8211c98d4f1db61fe1f2c32217765f41f532ecf501efc46ef5032f59c9d: [AVIR 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1593899/000119312526094159/avir-20251231.htm). - alpha:projection-evidence:document:40cc738b5fbd3fa003b7c1829117fe79cd6a470b7c94e2517c01938d7c88459f: [AVIR 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1593899/000119312526094159/avir-20251231.htm). - alpha:projection-evidence:document:c16946c22a0f7642cf389ef5571c6bde253d8c4508114ec8ab1999b8c832ccd0: [AVIR 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1593899/000119312526094159/avir-20251231.htm). - alpha:projection-evidence:document:9ff6707f20fd707526e2ce84ab2a965565c356ba38434025f7493e71883eb924: [AVIR 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1593899/000119312526094159/avir-20251231.htm). - alpha:projection-evidence:document:b2f3451aaeeb0f8396e6762730cb2743b7b44148603ba57c10f06133a7bfd2c6: [AVIR 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1593899/000119312526094159/avir-20251231.htm). - alpha:projection-evidence:document:384f36b2791a1c51feaabbd002b0117f0ae301c9489f9a564efeff6ea674a775: [AVIR 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1593899/000119312526094159/avir-20251231.htm). - alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab: [Audit](https://www.sec.gov/Archives/edgar/data/1593899/000119312525104019/d931077ddef14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/atea-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/atea-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/atea-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-22T06:32:45.044556+00:00; recorded 2026-10-22T06:32:45.044556+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.